![Michael Clifford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Clifford
Directeur/Bestuurslid bij SynDevRx, Inc.
Actieve functies van Michael Clifford
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | - | - |
Loopbaan van Michael Clifford
Opleiding van Michael Clifford
Cornell University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sectoraal
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
- Beurs
- Insiders
- Michael Clifford
- Ervaring